These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. MARs and MARBPs: key modulators of gene regulation and disease manifestation. Chattopadhyay S; Pavithra L Subcell Biochem; 2007; 41():213-30. PubMed ID: 17484130 [TBL] [Abstract][Full Text] [Related]
3. DNA methylation, chromatin inheritance, and cancer. Rountree MR; Bachman KE; Herman JG; Baylin SB Oncogene; 2001 May; 20(24):3156-65. PubMed ID: 11420732 [TBL] [Abstract][Full Text] [Related]
4. Causes and consequences of DNA hypomethylation in human cancer. Hoffmann MJ; Schulz WA Biochem Cell Biol; 2005 Jun; 83(3):296-321. PubMed ID: 15959557 [TBL] [Abstract][Full Text] [Related]
5. A transcriptional profiling study of CCAAT/enhancer binding protein targets identifies hepatocyte nuclear factor 3 beta as a novel tumor suppressor in lung cancer. Halmos B; Bassères DS; Monti S; D'Aló F; Dayaram T; Ferenczi K; Wouters BJ; Huettner CS; Golub TR; Tenen DG Cancer Res; 2004 Jun; 64(12):4137-47. PubMed ID: 15205324 [TBL] [Abstract][Full Text] [Related]
6. Mediator requirement for both recruitment and postrecruitment steps in transcription initiation. Wang G; Balamotis MA; Stevens JL; Yamaguchi Y; Handa H; Berk AJ Mol Cell; 2005 Mar; 17(5):683-94. PubMed ID: 15749018 [TBL] [Abstract][Full Text] [Related]
9. Methyl-CpG binding domain proteins and their involvement in the regulation of the MAGE-A1, MAGE-A2, MAGE-A3, and MAGE-A12 gene promoters. Wischnewski F; Friese O; Pantel K; Schwarzenbach H Mol Cancer Res; 2007 Jul; 5(7):749-59. PubMed ID: 17634428 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Stirzaker C; Song JZ; Davidson B; Clark SJ Cancer Res; 2004 Jun; 64(11):3871-7. PubMed ID: 15172996 [TBL] [Abstract][Full Text] [Related]
11. The dialectics of cancer: A theory of the initiation and development of cancer through errors in RNAi. Wynter CV Med Hypotheses; 2006; 66(3):612-35. PubMed ID: 16359827 [TBL] [Abstract][Full Text] [Related]
13. Remote control of gene transcription. West AG; Fraser P Hum Mol Genet; 2005 Apr; 14 Spec No 1():R101-11. PubMed ID: 15809261 [TBL] [Abstract][Full Text] [Related]
14. Subnuclear compartmentalization of sequence-specific transcription factors and regulation of eukaryotic gene expression. Corry GN; Underhill DA Biochem Cell Biol; 2005 Aug; 83(4):535-47. PubMed ID: 16094457 [TBL] [Abstract][Full Text] [Related]
15. Chromatin modifier enzymes, the histone code and cancer. Santos-Rosa H; Caldas C Eur J Cancer; 2005 Nov; 41(16):2381-402. PubMed ID: 16226460 [TBL] [Abstract][Full Text] [Related]
16. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue. Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695 [TBL] [Abstract][Full Text] [Related]
17. Active chromatin hub of the mouse alpha-globin locus forms in a transcription factory of clustered housekeeping genes. Zhou GL; Xin L; Song W; Di LJ; Liu G; Wu XS; Liu DP; Liang CC Mol Cell Biol; 2006 Jul; 26(13):5096-105. PubMed ID: 16782894 [TBL] [Abstract][Full Text] [Related]
18. hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Zinn RL; Pruitt K; Eguchi S; Baylin SB; Herman JG Cancer Res; 2007 Jan; 67(1):194-201. PubMed ID: 17210699 [TBL] [Abstract][Full Text] [Related]
19. Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription. Zhang Y; Fatima N; Dufau ML Mol Cell Biol; 2005 Sep; 25(18):7929-39. PubMed ID: 16135786 [TBL] [Abstract][Full Text] [Related]
20. Downregulation of c-fos gene transcription in cells transformed by E1A and cHa-ras oncogenes: a role of sustained activation of MAP/ERK kinase cascade and of inactive chromatin structure at c-fos promoter. Kukushkin AN; Abramova MV; Svetlikova SB; Darieva ZA; Pospelova TV; Pospelov VA Oncogene; 2002 Jan; 21(5):719-30. PubMed ID: 11850800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]